We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 130 results
  1. LPA1 receptors in the lateral habenula regulate negative affective states associated with alcohol withdrawal

    The role of lysophosphatidic acid (LPA) signaling in psychiatric disorders and drug abuse is significant. LPA receptors are widely expressed in the...

    Zhiheng Ren, Jiawei Hou, ... Rao Fu in Neuropsychopharmacology
    Article 14 April 2023
  2. The contribution of lysophosphatidic acid receptors in the response of human lower esophageal sphincter under the electrical field stimulation

    Background

    This study aims to identify the impact on the reaction while the clasp and sling fibers of the human lower esophageal sphincter are under...

    Yong Feng, Wei Wei, ... Jun-Feng Liu in BMC Gastroenterology
    Article Open access 18 May 2023
  3. Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders

    We have recently reported alterations in the plasma concentrations of lysophosphatidic acid (LPA) in patients with substance use disorders. In order...

    María Flores-López, Nuria García-Marchena, ... Antonia Serrano in Translational Psychiatry
    Article Open access 21 June 2023
  4. Lysophosphatidic acid contributes to myocardial ischemia/reperfusion injury by activating TRPV1 in spinal cord

    Lysophosphatidic acid (LPA) is a bioactive phospholipid that plays a crucial role in cardiovascular diseases. Here, we question whether LPA...

    Chao Wu, Meiyan Sun, ... Shufang He in Basic Research in Cardiology
    Article 18 January 2024
  5. Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects

    Lysophospholipids are a class of bioactive lipid molecules that produce their effects through various G protein-coupled receptors (GPCRs)....

    Jerold Chun, Gavin Giovannoni, Samuel F. Hunter in Drugs
    Article Open access 08 December 2020
  6. Neue Therapieverfahren für die idiopathische Lungenfibrose am Horizont

    Background

    Idiopathic pulmonary fibrosis (IPF) is a fatal age-related lung disease with limited treatment options.

    Objective

    This article gives an...

    Nataliia Artysh, Antje Prasse in Zeitschrift für Pneumologie
    Article 04 October 2023
  7. LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer

    Current studies have demonstrated that significant increased LPA levels to be observed in ascites in patients with ovarian cancer. Although several...

    Pengfei Zhao, Qingru Yun, ... Alatangaole Damirin in Medical Oncology
    Article 04 January 2022
  8. The LPA-CDK5-tau pathway mediates neuronal injury in an in vitro model of ischemia-reperfusion insult

    Lysophosphatidic acid (LPA) is a common glycerol phospholipid and an important extracellular signaling molecule. LPA binds to its receptors and...

    Yaya Wang, Jie Zhang, ... Zhaohui Zhang in BMC Neurology
    Article Open access 02 May 2022
  9. LPA1 antagonist BMS-986020 changes collagen dynamics and exerts antifibrotic effects in vitro and in patients with idiopathic pulmonary fibrosis

    Background

    Idiopathic pulmonary fibrosis (IPF) is a debilitating lung disease with limited treatment options. A phase 2 trial (NCT01766817) showed...

    Benjamin E. Decato, Diana Julie Leeming, ... Anne Minnich in Respiratory Research
    Article Open access 18 March 2022
  10. Different Profiles of the Triad of Lysophosphatidylcholine, Lysophosphatidic Acid, and Autotaxin in Patients with Neuropathic Pain Diseases: a Preliminary Observational Study

    The mechanisms underlying neuropathic pain remain unclear. Lysophosphatidic acid (LPA) is a bioactive phospholipid derived mainly from...

    Tatsuma Edamura, Masahiko Sumitani, ... Kanji Uchida in Pain and Therapy
    Article Open access 07 October 2022
  11. Lysophosphatidic Acid-Mediated Inflammation at the Heart of Heart Failure

    Purpose of Review

    The primary aim of this review is to provide an in-depth examination of the role bioactive lipids—namely lysophosphatidic acid (LPA)...

    Rajesh Chaudhary, Tahra Suhan, ... Ahmed Abdel-Latif in Current Cardiology Reports
    Article 10 February 2024
  12. Identification of immune associated potential molecular targets in proliferative diabetic retinopathy

    Background

    Diabetic retinopathy (DR) is one of the most common microvascular complications of diabetes and causes of blindness in developed countries....

    Ying Gao, Min Xue, ... Yirui Ge in BMC Ophthalmology
    Article Open access 19 January 2023
  13. Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis

    Idiopathic pulmonary fibrosis (IPF) remains a disease with poor survival. The pathogenesis is complex and encompasses multiple molecular pathways....

    Francesco Bonella, Paolo Spagnolo, Chris Ryerson in Drugs
    Article Open access 26 October 2023
  14. Abrogation of lysophosphatidic acid receptor 1 ameliorates murine vasculitis

    Background

    Lysophosphatidic acid (LPA), generated by autotaxin (ATX), is a bioactive lipid mediator that binds to the receptors (LPA 1–6 ), and serves...

    Chie Miyabe, Yoshishige Miyabe, ... Toshihiro Nanki in Arthritis Research & Therapy
    Article Open access 20 August 2019
  15. Pathological progression of osteoarthritis: a perspective on subchondral bone

    Osteoarthritis (OA) is a degenerative bone disease associated with aging. The rising global aging population has led to a surge in OA cases, thereby...

    Xuefei Li, Wenhua Chen, ... Zhijun Hu in Frontiers of Medicine
    Article 15 April 2024
  16. Emerging advanced approaches for diagnosis and inhibition of liver fibrogenesis

    Background

    Liver fibrosis results from chronic liver injury and is characterized by excessive deposition of extracellular matrix proteins including...

    Tamer A. Addissouky, Majeed M. A. Ali, ... Yuliang Wang in The Egyptian Journal of Internal Medicine
    Article Open access 12 February 2024
  17. The Multiple Functions of HB-EGF in Female Reproduction and Related Cancer: Molecular Mechanisms and Targeting Strategies

    Heparin-binding growth factor (HB-EGF) is a member of the epidermal growth factor (EGF) ligand family which has a crucial role in women’s health....

    Yuwei Zhang, Lujia Tang, ... Yanxiang Cheng in Reproductive Sciences
    Article 29 February 2024
  18. Therapeutic Approaches to Systemic Sclerosis: Recent Approvals and Future Candidate Therapies

    Systemic sclerosis is the rheumatic disease with the highest individual mortality. The severity of the disease is determined by the extent of...

    Alain Lescoat, David Roofeh, ... Dinesh Khanna in Clinical Reviews in Allergy & Immunology
    Article 01 September 2021
  19. Identification of lipid metabolism-related gene signature in the bone marrow microenvironment of multiple myelomas through deep analysis of transcriptomic data

    Dysregulated lipid metabolism in the bone marrow microenvironment (BMM) plays a vital role in multiple myeloma (MM) development, progression, and...

    Dan Feng, Zhen Wang, ... Shijun Li in Clinical and Experimental Medicine
    Article Open access 25 June 2024
  20. An update on targeted therapies in systemic sclerosis based on a systematic review from the last 3 years

    New molecular mechanisms that can be targeted with specific drugs have recently emerged for the treatment of systemic sclerosis (SSc) patients. Over...

    Corrado Campochiaro, Yannick Allanore in Arthritis Research & Therapy
    Article Open access 01 June 2021
Did you find what you were looking for? Share feedback.